Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1991 Nov;59(11):3859–3862. doi: 10.1128/iai.59.11.3859-3862.1991

Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon.

J M Beck 1, H D Liggitt 1, E N Brunette 1, H J Fuchs 1, J E Shellito 1, R J Debs 1
PMCID: PMC258968  PMID: 1682252

Abstract

Pneumocystis carinii pneumonia in patients with AIDS may result from impaired local release of gamma interferon from lung lymphocytes and subsequent failure of macrophage activation. We tested this hypothesis with mice rendered immunodeficient by selective depletion of CD4+ lymphocytes and inoculated intratracheally with P. carinii. After aerosol administration of recombinant murine gamma interferon, the intensity of P. carinii infection in these mice was reduced in comparison with that in mice not treated with gamma interferon. Histologic scoring of lung tissue did not reveal additional pulmonary inflammation attributable to gamma interferon. Aerosol administration of gamma interferon may reduce the intensity of P. carinii infection by augmentation of host defense, despite persistent CD4+ lymphocyte depletion.

Full text

PDF
3859

Images in this article

3861Image
on p.3861

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams L. B., Hibbs J. B., Jr, Taintor R. R., Krahenbuhl J. L. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol. 1990 Apr 1;144(7):2725–2729. [PubMed] [Google Scholar]
  2. Curtis J. L., Kaltreider H. B. Characterization of bronchoalveolar lymphocytes during a specific antibody-forming cell response in the lungs of mice. Am Rev Respir Dis. 1989 Feb;139(2):393–400. doi: 10.1164/ajrccm/139.2.393. [DOI] [PubMed] [Google Scholar]
  3. Debs R. J., Fuchs H. J., Philip R., Montgomery A. B., Brunette E. N., Liggitt D., Patton J. S., Shellito J. E. Lung-specific delivery of cytokines induces sustained pulmonary and systemic immunomodulation in rats. J Immunol. 1988 May 15;140(10):3482–3488. [PubMed] [Google Scholar]
  4. Debs R., Brunette E., Fuchs H., Lin E., Shah M., Hargis A., Montgomery A. B. Biodistribution, tissue reaction, and lung retention of pentamidine aerosolized as three different salts. Am Rev Respir Dis. 1990 Nov;142(5):1164–1167. doi: 10.1164/ajrccm/142.5.1164. [DOI] [PubMed] [Google Scholar]
  5. Drath D. B. Modulation of pulmonary macrophage superoxide release and tumoricidal activity following activation by biological response modifiers. Immunopharmacology. 1986 Oct;12(2):117–126. doi: 10.1016/0162-3109(86)90037-8. [DOI] [PubMed] [Google Scholar]
  6. Fuchs H. J., Czarniecki C. W., Chiu H. H., Sniezek M., Shellito J. E. Interferon-gamma increases alveolar macrophage Ia antigen expression despite oral administration of dexamethasone to rats. Am J Respir Cell Mol Biol. 1989 Dec;1(6):525–532. doi: 10.1165/ajrcmb/1.6.525. [DOI] [PubMed] [Google Scholar]
  7. Krishnan V. L., Meager A., Mitchell D. M., Pinching A. J. Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor-alpha production in Pneumocystis carinii pneumonia. Clin Exp Immunol. 1990 May;80(2):156–160. doi: 10.1111/j.1365-2249.1990.tb05225.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Masur H., Jones T. C. The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J Exp Med. 1978 Jan 1;147(1):157–170. doi: 10.1084/jem.147.1.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Masur H., Lane H. C., Kovacs J. A., Allegra C. J., Edman J. C. NIH conference. Pneumocystis pneumonia: from bench to clinic. Ann Intern Med. 1989 Nov 15;111(10):813–826. doi: 10.7326/0003-4819-111-10-813. [DOI] [PubMed] [Google Scholar]
  10. Murray H. W., Gellene R. A., Libby D. M., Rothermel C. D., Rubin B. Y. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma. J Immunol. 1985 Oct;135(4):2374–2377. [PubMed] [Google Scholar]
  11. Murray H. W., Rubin B. Y., Masur H., Roberts R. B. Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med. 1984 Apr 5;310(14):883–889. doi: 10.1056/NEJM198404053101404. [DOI] [PubMed] [Google Scholar]
  12. Murray H. W., Scavuzzo D. A., Kelly C. D., Rubin B. Y., Roberts R. B. T4+ cell production of interferon gamma and the clinical spectrum of patients at risk for and with acquired immunodeficiency syndrome. Arch Intern Med. 1988 Jul;148(7):1613–1616. [PubMed] [Google Scholar]
  13. Phair J., Muñoz A., Detels R., Kaslow R., Rinaldo C., Saah A. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med. 1990 Jan 18;322(3):161–165. doi: 10.1056/NEJM199001183220304. [DOI] [PubMed] [Google Scholar]
  14. Rudy T., Opelz G., Gerlach R., Daniel V., Schimpf K. Correlation of in vitro immune defects with impaired gamma interferon response in human-immunodeficiency-virus-infected individuals. Vox Sang. 1988;54(2):92–95. doi: 10.1111/j.1423-0410.1988.tb01623.x. [DOI] [PubMed] [Google Scholar]
  15. Saltini C., Hance A. J., Ferrans V. J., Basset F., Bitterman P. B., Crystal R. G. Accurate quantification of cells recovered by bronchoalveolar lavage. Am Rev Respir Dis. 1984 Oct;130(4):650–658. doi: 10.1164/arrd.1984.130.4.650. [DOI] [PubMed] [Google Scholar]
  16. Shear H. L., Valladares G., Narachi M. A. Enhanced treatment of Pneumocystis carinii pneumonia in rats with interferon-gamma and reduced doses of trimethoprim/sulfamethoxazole. J Acquir Immune Defic Syndr. 1990;3(10):943–948. [PubMed] [Google Scholar]
  17. Shellito J., Suzara V. V., Blumenfeld W., Beck J. M., Steger H. J., Ermak T. H. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest. 1990 May;85(5):1686–1693. doi: 10.1172/JCI114621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Von Behren L. A., Pesanti E. L. Uptake and degradation of Pneumocystis carinii by macrophages in vitro. Am Rev Respir Dis. 1978 Dec;118(6):1051–1059. doi: 10.1164/arrd.1978.118.6.1051. [DOI] [PubMed] [Google Scholar]
  19. Walzer P. D., Powell R. D., Jr, Yoneda K., Rutledge M. E., Milder J. E. Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia. Infect Immun. 1980 Mar;27(3):928–937. doi: 10.1128/iai.27.3.928-937.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES